Columbia Structural Heart and Valve Center

The Columbia Structural Heart and Valve Center is a leading program for world-class valve and structural heart care. We offer the lightest level of comprehensive, minimally invasive care for valve disease, including the most advanced treatments available today. Our providers regularly play an important role in developing new and innovative solutions, and we participate in the latest clinical trials for new therapies and devices. 

Highlights of Our Center

Pioneers in Valve Disease Treatment

Our physicians are established leaders for innovative treatment solutions for valve disease. Columbia played a foundational role in the development and adoption of transcatheter aortic valve replacement (TAVRs), and continues to expand today’s treatments, including studies examining new therapy options for mitral and tricuspid valve disease.

Unmatched Success

Our outstanding success rate speaks volumes about our experience and expertise. The Columbia Structural Heart and Valve Center performs over 1,000 structural procedures per year, including many complex, high-risk procedures. According to a recent New York State Department of Health report, only the Columbia Structural Heart and Valve Center performed significantly better than the state average for TAVRs—no other area hospital came close.

The Skill to Train Other Experts

Our center serves as one of just a few training sites in the U.S. on TAVRs. In fact, CUIMC has trained well over 50 percent of the heart teams in the U.S. who now perform TAVRs in their own centers.

An Epicenter for Research

Columbia’s proud legacy of innovation continues as a major site for national and international clinical trials. Our providers regularly lead research that opens the door for tomorrow’s minimally invasive cardiac treatments. Our Mitral & Tricuspid Center is the most advanced center of its kind, home to the latest technologies, clinical trials, and world-class procedural expertise.